MJHS Institute for Innovation in Palliative Care
New York, New York, United States
Training centre in New York City, New York
39 Broadway #3, New York, NY 10006
About MJHS Institute for Innovation in Palliative Care
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MJHS Institute for Innovation in Palliative Care
During the past decade, MJHS Institute for Innovation in Palliative Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
2013-11-01
2015-08-01
Terminated
199
A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men
2013-08-01
2014-03-01
Completed
16
A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function
2013-09-01
2013-12-01
Completed
16
The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST
2013-12-01
2016-07-01
Completed
140
A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients
2016-01-28
2017-05-23
Completed
244
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
2016-12-12
2021-06-15
Completed
46
A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients
2016-09-01
2017-11-28
Completed
50
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MJHS Institute for Innovation in Palliative Care"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "New York Headache Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at MJHS Institute for Innovation in Palliative Care
According to Clinical.Site data, the most researched conditions in "MJHS Institute for Innovation in Palliative Care" are
"Cancer" (1 trials), "Constipation" (1 trials), "Migraine Disorders" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "MJHS Institute for Innovation in Palliative Care" in a lesser frequency.
Clinical Trials Intervention Types at MJHS Institute for Innovation in Palliative Care
Most popular intervention types in "MJHS Institute for Innovation in Palliative Care" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Naloxegol" (1 trials), "Placebo" (1 trials) and "non-invasive transcranial direct current stimulation (tDCS)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MJHS Institute for Innovation in Palliative Care
The vast majority of trials in "MJHS Institute for Innovation in Palliative Care" are
2 trials for "All" genders.
Clinical Trials Status at MJHS Institute for Innovation in Palliative Care
Currently, there are NaN active trials in "MJHS Institute for Innovation in Palliative Care".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MJHS Institute for Innovation in Palliative Care,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MJHS Institute for Innovation in Palliative Care, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".